2008-006903-22: Narrow band UV-B phototherapy and fluticasone proprionate versus narrow band UV-B phototherapy and placebo for the treatment of active vitiligo: a randomized double blind controlled trial |
|
|
| Ongoing | 4 | 64 | Europe | Cutivate, RVG06933, Cutivate, Cutivate | Academic Medical Center | Narrow band ultra violet B phototherapy is the gold standard for the treatment of vitiligo vulgaris. Ultra violet A and fluticasone proprionate (cutivate) together have shown significant better repigmentation than both treatments alone in a study by Westerhof et al in 1999. We expect that the combination of narrow band ultra violet B and fluticasone proprionate will have a significantly better result in terms of repigmentation for the treatment of vitiligo. | | | | |
ChiCTR2100041678: A randomized, self-controlled study of 0.05% fluticasone propionate cream combined with 0.005% carpotriol ointment or single treatment for mild to moderate plaque psoriasis |
|
|
| Recruiting | 4 | 60 | | Apply 0.005% carpotriol ointment externally in the morning and 0.05% fluticasone propionate cream externally in the evening ;Apply 0.05% fluticasone propionate cream externally, twice daily | Beijing Friendship Hospital Capital Medical University; Beijing Friendship Hospital, self-raised | psoriasisi | | | | |
